These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 34533885)

  • 1. Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.
    Adeniji N; Dhanasekaran R
    Hepatol Commun; 2021 Dec; 5(12):1972-1986. PubMed ID: 34533885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.
    Shimauchi Y; Tanaka M; Kuromatsu R; Ogata R; Tateishi Y; Itano S; Ono N; Yutani S; Nagamatsu H; Matsugaki S; Yamasaki S; Tanikawa K; Sata M
    Oncol Rep; 2000; 7(2):249-56. PubMed ID: 10671666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.
    Shahini E; Pasculli G; Solimando AG; Tiribelli C; Cozzolongo R; Giannelli G
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma.
    Wang X; Kwak KJ; Yang Z; Zhang A; Zhang X; Sullivan R; Lin D; Lee RL; Castro C; Ghoshal K; Schmidt C; Lee LJ
    PLoS One; 2018; 13(6):e0198552. PubMed ID: 29879168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
    An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
    BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma surveillance: An evidence-based approach.
    Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
    World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
    Worland T; Harrison B; Delmenico L; Dowling D
    J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
    Deng LX; Mehta N
    Dig Dis Sci; 2020 Dec; 65(12):3456-3462. PubMed ID: 32860090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for Hepatocellular Carcinoma (HCC): An Update.
    Li D; Satomura S
    Adv Exp Med Biol; 2015; 867():179-93. PubMed ID: 26530367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis.
    Daher D; Seif El Dahan K; Cano A; Gonzales M; Ransom C; Jaurez E; Carranza O; Quirk L; Morgan T; Gopal P; Patel MS; Lieber S; Louissaint J; Cotter TG; VanWagner LB; Yang JD; Parikh ND; Yopp A; Rich NE; Singal AG
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):295-304.e2. PubMed ID: 37573986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.
    Song PP; Xia JF; Inagaki Y; Hasegawa K; Sakamoto Y; Kokudo N; Tang W
    World J Gastroenterol; 2016 Jan; 22(1):262-74. PubMed ID: 26755875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic clues for recurrent hepatocellular carcinoma: comparison of tumour markers and imaging studies.
    Ando E; Tanaka M; Yamashita F; Kuromatsu R; Takada A; Fukumori K; Yano Y; Sumie S; Okuda K; Kumashiro R; Sata M
    Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):641-8. PubMed ID: 12840676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer markers for hepatocellular carcinoma.
    Marrero JA; Lok AS
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S113-9. PubMed ID: 15508074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.
    Hu S; Liu Y; Yang Q; Chen L; Chai H; Xiao M; Qi C; Qiu W
    Invest New Drugs; 2023 Jun; 41(3):532-538. PubMed ID: 37099161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
    Takada H; Tsuchiya K; Yasui Y; Nakakuki N; Tamaki N; Suzuki S; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Izumi N
    Cancer Med; 2016 Nov; 5(11):3111-3120. PubMed ID: 27748052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis.
    Conti F; Dall'Agata M; Gramenzi A; Biselli M
    Biomark Med; 2015; 9(12):1343-51. PubMed ID: 26580585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein in patients with hepatocellular carcinoma.
    Kuromatsu R; Tanaka M; Tanikawa K
    Liver; 1993 Aug; 13(4):177-82. PubMed ID: 7690873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of serological tumor biomarkers for surveillance of hepatocellular carcinoma in patients undergoing dialysis.
    Toyoda H; Kikuchi K; Tsuruta Y; Hiraoka A; Tsuji K; Tanaka J
    Nephrol Dial Transplant; 2021 May; 36(6):1097-1103. PubMed ID: 33009910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.